Health-related quality-of-life analysis from the TRINOVA-1 study of weekly paclitaxel plus trebananib or placebo in women with recurrent ovarian cancer
2010 ◽
Vol 28
(15_suppl)
◽
pp. 5044-5044
Keyword(s):
2013 ◽
Vol 14
(1)
◽
pp. 157-163
◽
Keyword(s):
2018 ◽
Vol 158
◽
pp. 153-159
◽
Keyword(s):